purpos
lianhuaqingwen
lh
tradit
chines
medicin
tcm
formula
use
treat
influenza
exert
broadspectrum
antivir
effect
seri
influenza
virus
immun
regulatori
effect
ding
et
al
goal
studi
demonstr
antivir
activ
lh
novel
viru
potenti
effect
regul
host
immun
respons
method
antivir
activ
lh
assess
vero
cell
use
cpe
plaqu
reduct
assay
effect
lh
virion
morpholog
visual
transmiss
electron
microscop
proinflammatori
cytokin
express
level
upon
infect
cell
measur
realtim
quantit
pcr
assay
result
lh
significantli
inhibit
replic
vero
cell
markedli
reduc
proinflammatori
cytokin
product
mrna
level
furthermor
lh
treatment
result
abnorm
particl
morpholog
virion
cell
conclus
lh
significantli
inhibit
replic
affect
viru
morpholog
exert
antiinflammatori
activ
vitro
find
indic
lh
protect
viru
attack
make
use
novel
strategi
control
diseas
coronavirus
group
envelop
virus
name
coronari
appear
posit
singlestrand
rna
genom
addit
six
known
strain
coronavirus
infecti
human
novel
coronaviru
detect
recent
wuhan
china
like
two
highli
pathogen
coronavirus
sarscov
merscov
also
caus
sever
respiratori
ill
even
death
moreov
popul
suscept
highli
pathogen
coronavirus
contribut
larg
outbreak
evolv
public
health
event
highlight
necess
prepar
futur
reemerg
novel
emerg
virus
similar
sarscov
merscov
initi
zoonot
transmiss
like
bat
spread
rapidli
among
human
basic
reproduct
number
persontoperson
spread
mean
infect
case
grow
exponenti
rate
februari
case
report
china
includ
suspect
case
sustain
increas
predict
initi
patient
cluster
confirm
infect
report
wuhan
pneumonia
unknown
aetiolog
bore
resembl
sarscov
merscov
infect
associ
icu
admiss
high
mortal
moreov
high
concentr
cytokin
http
receiv
februari
receiv
revis
form
march
accept
march
record
plasma
patient
requir
icu
admiss
gcsf
suggest
cytokin
storm
associ
diseas
sever
retrospect
clinic
studi
indic
risk
fatal
among
hospit
case
singlecent
case
seri
hospit
patient
infect
fatal
risk
could
even
larg
number
undetect
rel
mild
infect
howev
challeng
judg
sever
predict
consequ
inform
avail
far
sinc
specif
antivir
treatment
current
avail
support
care
includ
symptomat
control
prevent
complic
remain
critic
therapeut
regimen
especi
prevent
acut
respiratori
distress
syndrom
although
control
still
present
multipl
challeng
short
term
potent
antivir
drug
urgent
develop
present
drug
effect
elimin
improv
symptom
promis
antivir
drug
remdesivir
current
clinic
develop
treatment
ebola
viru
infect
howev
efficaci
safeti
remdesivir
pneumonia
patient
need
assess
clinic
trial
addit
prevent
treatment
tranditon
chines
medicin
receiv
broad
adopt
especi
treat
case
mild
symptom
lianhuaqingwen
lh
chines
patent
medicin
compos
herb
play
posit
role
treatment
retrospect
analysi
clinic
record
conduct
infect
patient
wuhan
ninth
hospit
cr
wisco
gener
hospit
lh
combin
could
significantli
reliev
cardin
symptom
reduc
cours
make
success
includ
guidelin
diagnosi
treatment
novel
coronaviru
pneumonia
trial
fourthfifth
sixthseventh
edit
issu
nation
health
commiss
peopl
republ
china
also
recommend
provinci
health
commiss
includ
hubei
beij
shanghai
well
nation
administr
tradit
chines
medicin
treatment
moreov
lh
exert
broadspectrum
effect
seri
influenza
virus
inhibit
viral
propag
regul
immun
function
achiev
similar
therapeut
effect
oseltamivir
reduc
cours
viru
infect
notabl
antiinfluenza
activ
lh
infect
mice
might
depend
regul
cytokin
particularli
cytokin
storm
associ
cytokin
present
studi
evalu
antivir
antiinflammatori
effici
lh
clinic
isol
guangzhou
vitro
african
green
monkey
kidney
epitheli
vero
cell
human
hepatocellular
carcinoma
cell
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
usa
supplement
fetal
bovin
serum
fb
clinic
isol
viru
genebank
access
propag
vero
cell
viral
titer
determin
tissu
cultur
infect
dose
tcid
accord
cytopath
effect
use
reedmuench
method
infect
experi
perform
biosafeti
laboratori
lh
capsul
lot
obtain
yile
pharmaceut
co
ltd
shijiazhuang
china
uplc
fingerprint
lh
consist
common
peak
common
peak
identifi
similar
batch
lh
capsul
sampl
supplementari
fig
black
powder
raw
materi
lh
first
dissolv
dimethyl
sulfoxid
dmso
mgml
shake
min
room
temperatur
lh
solut
dilut
serumfre
dmem
mgml
stock
solut
store
use
remdesivir
kindli
provid
prof
jiancun
zhang
guangzhou
institut
biomedicin
health
chines
academi
scienc
dissolv
dmso
mm
store
use
dmem
fb
use
dilut
buffer
followup
experi
cytotox
effect
lh
vero
cell
evalu
methyl
thiazolyl
tetrazolium
mtt
assay
briefli
monolay
vero
cell
cell
plate
rins
phosphatebuff
salin
pb
follow
incub
indic
concentr
lh
h
cell
stain
mtt
solut
mgml
h
supernat
remov
form
formazan
crystal
dissolv
dmso
absorb
measur
nm
use
multiskan
spectrum
reader
thermo
fisher
usa
cytotox
concentr
cc
calcul
graphpad
prism
softwar
vero
cell
monolay
grown
plate
inocul
tcid
coronaviru
strain
h
inoculum
remov
cell
subsequ
incub
indic
concentr
lh
posit
control
remdesivir
follow
h
incub
infect
cell
shown
cpe
microscop
percentag
cpe
lhtreat
cell
record
inhibit
concentr
ic
virusinduc
cpe
lh
calcul
reedmuench
method
vero
cell
monolay
plate
infect
plaqueform
unit
pfu
h
incub
cell
monolay
cover
agar
overlay
final
concentr
agar
fb
indic
concentr
lh
remdesivir
plate
incub
h
co
subsequ
agar
overlay
remov
cell
monolay
fix
formalin
stain
crystal
violet
plaqu
count
photograph
cell
monolay
plate
rins
pb
expos
coronaviru
multipl
infect
moi
h
inoculum
remov
replac
indic
concentr
lh
mocktreat
dmem
supplement
fb
subsequ
h
incub
co
cell
harvest
rna
isol
qpcr
describ
previous
primer
probe
sequenc
use
analysi
list
supplementari
tabl
rel
mrna
express
calcul
use
method
gapdh
intern
refer
gene
monolay
vero
cell
plate
incub
moi
h
viru
inoculum
remov
replac
dmem
medium
supplement
fb
contain
lh
remdesivir
h
pi
cell
fix
dehydr
embed
describ
previous
l
runfeng
et
al
pharmacolog
research
ultrathin
section
nm
embed
cell
prepar
deposit
onto
formvarco
copper
grid
mesh
stain
uranyl
acet
lead
citrat
observ
plu
transmiss
electron
microscopi
japan
electron
optic
laboratori
co
ltd
plu
statist
analysi
perform
use
graphpad
prism
softwar
differ
mrna
express
level
cytokin
compar
use
oneway
analysi
varianc
anova
valu
p
consid
statist
signific
cell
viabil
lh
remdesivir
treatment
determin
mtt
assay
vero
cell
lh
show
unappar
cytotox
cell
line
concentr
fig
c
posit
control
remdesivir
show
cytotox
cell
concentr
fig
investig
antivir
effect
lh
viru
vero
cell
infect
tcid
viru
incub
lh
variou
concentr
h
shown
fig
lh
inhibit
replic
viru
ic
valu
cpe
assay
fig
meanwhil
treatment
lh
follow
infect
also
dosedepend
inhibitori
effect
plaqu
format
viru
fig
select
remdesivir
posit
control
studi
result
show
remdesivir
potent
inhibit
virusinduc
cpe
ic
total
plaqu
format
inhibit
fig
c
confirm
efficaci
lh
inhibit
viru
replic
cell
detect
viral
particl
ultrathin
section
infect
cell
electron
microscopi
h
pi
viral
particl
found
cytoplasm
intracellular
vesicl
endoplasm
reticulum
cell
membran
present
spheric
crownlik
appear
typic
coronaviru
morpholog
fig
g
lh
ml
posit
control
remdesivir
treatment
result
reduct
number
virion
compar
mocktreat
infect
cell
fig
interest
note
virion
surfac
lhtreat
cell
present
spindl
sharp
contrast
typic
spheric
particl
mocktreat
cell
fig
determin
effect
lh
express
cytokin
chemokin
induc
mrna
express
level
detect
compar
lhtreat
mocktreat
cell
result
show
elev
express
four
cytokin
significantli
inhibit
lh
treatment
concentrationdepend
manner
fig
start
decemb
pandem
respiratori
ill
caus
novel
coronaviru
name
sweep
mainland
china
viru
spread
sever
foreign
countri
threaten
trigger
global
outbreak
sever
antivir
agent
envisag
control
prevent
viral
infect
antivir
assay
vitro
howev
efficaci
safeti
novel
candid
need
valid
vivo
even
clinic
approv
medicin
mean
take
month
year
clinic
practic
present
symptomat
support
treatment
remain
key
clinic
practic
thu
tradit
chines
medicin
tcm
carri
antivir
effect
symptomat
relief
might
bring
clinic
benefit
classic
tcm
prescript
respiratori
diseas
previou
studi
show
lh
exhibit
vitro
antiinfluenza
activ
ic
rang
demonstr
lh
also
compar
antivir
potenc
viru
ic
valu
fig
transmiss
electron
microscopi
tem
potent
tool
observ
viru
entri
viru
particl
assembl
viral
ultrastructur
bud
plasma
membran
understand
antivir
detail
lh
em
pictur
taken
group
abund
viru
particl
assembl
surfac
membran
cytoplasm
plasma
vesicl
infect
cell
decreas
treatment
lh
notabl
slight
deform
viru
particl
seen
lh
treatment
requir
us
make
studi
highli
pathogen
coronavirus
sarscov
merscov
caus
fatal
pneumonia
mainli
associ
rapid
viru
replic
massiv
inflammatori
cell
infiltr
elev
proinflammatori
cytokinechemokin
respons
although
pathophysiolog
fatal
pneumonia
caus
highli
pathogen
coronavirus
complet
understood
accumul
evid
suggest
cytokin
storm
play
crucial
role
caus
fatal
pneumonia
excess
amount
proinflammatori
cytokin
report
eg
serum
sar
patient
similar
serum
mer
patient
chaolin
huang
et
al
confirm
occurr
cytokin
storm
patient
icu
rather
nonicu
patient
base
excess
cytokin
respons
suxin
wan
et
al
claim
level
could
use
one
base
predict
outcom
prognosi
studi
host
cell
infect
increas
cytokin
releas
suppress
lh
dosedepend
manner
chang
cytokin
profil
suggest
lh
might
potenti
effect
inhibit
cytokin
storm
induc
also
need
valid
vivo
sinc
launch
lh
wide
use
broad
spectrum
antivir
agent
clinic
practic
especi
variou
respiratori
viru
infect
previou
studi
shown
lh
broad
spectrum
effect
seri
influenza
virus
interf
viral
host
reaction
although
lh
significantli
reliev
clinic
symptom
underli
mechan
antivir
effect
coronaviru
especi
still
elus
studi
demonstr
lh
exert
anticoronaviru
activ
inhibit
viru
replic
reduc
cytokin
releas
host
cell
support
clinic
applic
lh
combin
exist
therapi
treat
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
